{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"36","value":"50"},{"groupId":"OG001","spread":"34.69","value":"50"}]}],"title":"Anxiety (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"31.91","value":"36.11"},{"groupId":"OG001","spread":"34.46","value":"60.32"}]}],"title":"Body Image (FS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.25","value":"16.67"},{"groupId":"OG001","spread":"16.27","value":"9.52"}]}],"title":"Coughing (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"31.55","value":"54.17"},{"groupId":"OG001","spread":"33.13","value":"42.86"}]}],"title":"Dry mouth and sticky saliva (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"50.92","value":"44.44"},{"groupId":"OG001","spread":"16.27","value":"9.52"}]}],"title":"Neurological problems (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"47.14","value":"66.67"},{"groupId":"OG001","spread":"25.20","value":"42.86"}]}],"title":"Opening mouth (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.41","value":"41.67"},{"groupId":"OG001","spread":"28.35","value":"27.38"}]}],"title":"Pain in the head and neck (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.25","value":"50"},{"groupId":"OG001","spread":"35.63","value":"61.90"}]}],"title":"Social contact (FS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.52","value":"25"},{"groupId":"OG001","spread":"35.63","value":"28.57"}]}],"title":"Problems with senses (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"45.90","value":"45.83"},{"groupId":"OG001","spread":"13.11","value":"9.52"}]}],"title":"Shoulder problems (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"13.98","value":"25"},{"groupId":"OG001","spread":"31.71","value":"20.63"}]}],"title":"Skin problems (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"47.14","value":"66.67"},{"groupId":"OG001","spread":"46","value":"57.14"}]}],"title":"Swelling in the neck (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"43.3","value":"50"},{"groupId":"OG001","spread":"29.83","value":"26.19"}]}],"title":"Social eating (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.15","value":"55.24"},{"groupId":"OG001","spread":"34.53","value":"48.10"}]}],"title":"Speech problems (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"29.46","value":"45.83"},{"groupId":"OG001","spread":"33.97","value":"29.76"}]}],"title":"Problems with Swallowing (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"33.33","value":"33.33"},{"groupId":"OG001","spread":"26.23","value":"80.95"}]}],"title":"Problems with Sexuality (FS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.22","value":"22.22"},{"groupId":"OG001","spread":"24.84","value":"22.22"}]}],"title":"Problems with teeth (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.67","value":"25"},{"groupId":"OG001","spread":"26.23","value":"14.29"}]}],"title":"Weight loss (SS)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"47.14","value":"33.33"},{"groupId":"OG001","spread":"23","value":"28.57"}]}],"title":"Problems with wound healing (SS)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"7"}],"units":"Participants"}],"description":"The EORTC QLQ-HN43 is a 43-question assessment for determining the health-related quality of life of head and neck cancer patients participating in clinical trials. Patients indicate which symptoms/problems they have experienced during the past week, from \"1 Not at All\" to \"4 Very Much\".\n\nThe assessment was scored according to the \"EORTC QLQ-C30 Scoring Manual\", reporting data as 19 subscales with scores from 0-100. A high scale score represents a higher response level.\n\nA high functional scale score (FS) represent a high/healthy level of function and includes body image, social contact, \\& sexuality A high symptom scale score (SS) represent a high level of symptomatology/problems and includes anxiety, cough, head and neck pain, swallowing, neurologic problems, senses, speech, social eating, weight loss, problems w/ skin, shoulder, wound healing, dry mouth, opening mouth, neck swelling, \\& teeth.\n\nThis outcome will report the mean score of each subscale.","dispersionType":"Standard Deviation","groups":[{"description":"Patients received celecoxib PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity.\n\nCelecoxib: Given PO or via feeding tube\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"OG000","title":"Celecoxib Arm"},{"description":"Patients received placebo PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity.\n\nPlacebo: Given PO or via feeding tube\n\nQuality-of-Life Assessment: Ancillary studies\n\nQuestionnaire Administration: Ancillary studies","id":"OG001","title":"Placebo Arm"}],"paramType":"MEAN","populationDescription":"One participant on Arm 1 withdrew consent from the study treatment before the Post-Operation visit and was not evaluable for this endpoint.","reportingStatus":"POSTED","timeFrame":"Up to 29 days after surgery (up to 32 days after initiation of study treatment)","title":"To Assess the Effect of Celecoxib Therapy on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (EORTC QLQ-HN43) Compared to Placebo.","type":"SECONDARY","unitOfMeasure":"units on a scale"}